The Pharmacovigilance (PHV) department is the heart of drug safety, but its health depends entirely on the arteries and veins that feed it—the allied functions across your organization.

When a regulatory agency (like the MHRA, FDA, or the EMA) arrives for an inspection, they aren’t just looking at your PHV team’s SOPs and case processing metrics. They follow the data trail, and that trail leads them directly into the operations of nearly every other department.

The key takeaway for any Marketing Authorization Holder (MAH) is this: The success of a PHV inspection is largely determined by how well your cross-functional stakeholders have fared. It is the PV department’s primary responsibility to train, manage oversight, and ensure these allies perform their safety-related work flawlessly.

The Pharmacovigilance Stakeholder Map 🗺️

While the PHV Department holds the Primary responsibility, the integrity of the safety system is guaranteed by the diligence of these Secondary Stakeholders:

1. The Data & System Gatekeepers

These groups are responsible for the infrastructure and flow of safety information. A breakdown here can halt the entire system.

• Information Technology (IT) and Validation Team: Manages the validated safety database, ensuring it is secure, compliant (e.g., CFR Part 11), and available 24/7. They also handle the E2B reporting systems.
• BCP Team (Business Continuity Planning): Ensures the PV system can remain operational during a disaster (e.g., natural disaster, system failure). Auditors will check that the recovery plan for the safety database and QPPV function is robust and tested.
• QPPV Office: While often part of the PHV structure, it must be audited independently. The QPPV’s 24×7 availability, access to the PSMF, and formal regulatory notification of their details are critical compliance points.
• Administration and Front Desk: Often the first point of contact for external communication. They must be trained to recognize and immediately forward incoming adverse event reports (via mail, fax, or phone) to the PHV department.

2. The Product & Documentation Specialists

These teams ensure the safety profile is accurately and consistently reflected in official company documents.

• Regulatory Affairs: Handles the timely submission of safety variations and periodic reports (PSURs/PBRERs). They ensure the Core Safety Information (CSI) is current and communicated globally.
• Artwork and Labeling: Critical for compliance. They ensure the approved safety warnings are incorporated correctly, without delay, into the global and local patient information leaflets and packaging artwork.
• Product Quality: Responsible for product quality complaints (PQCs). They must have a robust process for distinguishing a PQC from an Adverse Event (AE) and correctly forwarding any safety-related information to PHV.
• Clinical (Operations/Data Management): Manages the collection and reporting of safety data from clinical trials (ICSRs). Auditors verify the accuracy and timeliness of reporting from sites and data transfer to the PV department.

3. The Front Line & Legal Safeguards

These groups are at the highest risk of generating unsolicited safety data that must be captured, or protecting the company when an issue arises.

• Medical Information: A high-risk channel. Personnel must be expertly trained in capturing all minimum criteria for an AE and rapidly escalating the report to PHV.
• Marketing / Sales: They are constantly speaking with prescribers and patients. Any member of the sales force or marketing team who receives an AE report is legally obligated to forward it immediately. This department is a frequent source of critical audit findings related to missed or delayed reports.
• Market Research and allied: Auditors will check whether contracts with market research firms explicitly include PV reporting obligations and whether internal staff overseeing these programs are trained to identify solicited AEs.
• Legal: They review safety agreements, manage litigation related to product safety, and ensure all PV-related disclaimers and privacy policies are compliant.
• Business Partners/Vendors/Affiliates: As external stakeholders, their safety contracts (Safety Data Exchange Agreements or SDEAs) and their compliance history are primary targets for audit.

The Ultimate Stakeholders: Reporters of Adverse Events

Can we consider the people who report adverse events—the patients and healthcare professionals (HCPs)—as stakeholders?

Absolutely, yes.

While they are not internal functions to be audited, they are the most vital external stakeholders and the ultimate focus of the entire PHV system. Without their voluntary reports, the PHV system would lose the critical real-world data needed to monitor a product’s safety profile.

Your entire PHV system, from the QPPV office to the marketing team, is designed to successfully facilitate the collection and assessment of the safety information they provide.

The next time you prepare for an inspection, remember you are preparing the entire organization. PHV compliance is a team sport, and the PV department is the coach, the referee, and the ultimate accountable party for the performance of the entire team.